WealthShield Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,421
Closed -$3.04M 492
2024
Q3
$3.04M Buy
9,421
+4,452
+90% +$1.46M 0.41% 73
2024
Q2
$1.55M Sell
4,969
-3,322
-40% -$976K 0.24% 114
2024
Q1
$2.36M Buy
8,291
+2,034
+33% +$595K 0.38% 78
2023
Q4
$1.8M Buy
6,257
+3,307
+112% +$901K 0.3% 96
2023
Q3
$793K Buy
+2,950
New +$736K 0.12% 171
2021
Q3
Sell
-211
Closed -$51K 257
2021
Q2
$51K Sell
211
-1,209
-85% -$297K 0.01% 470
2021
Q1
$353K Buy
1,420
+2
+0.1% +$477 0.06% 185
2020
Q4
$326K Buy
1,418
+470
+50% +$108K 0.06% 227
2020
Q3
$241K Buy
948
+71
+8% +$17.6K 0.08% 223
2020
Q2
$207K Buy
+877
New +$200K 0.1% 194

Other funds holding AMGN

WealthShield Partners's AMGN Position: Q4 2024 in Review

WealthShield Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 9,421 shares — an estimated $3.04M sold.

WealthShield Partners first reported a position in AMGN in Q2 2020 and held it in 10 quarters. The position peaked at $3.04M in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • WealthShield Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • WealthShield Partners sold 9,421 Amgen shares in Q4 2024, an estimated $3.04M.
  • WealthShield Partners first reported a position in Amgen in Q2 2020 and held it in 10 quarters.
  • WealthShield Partners's Amgen position peaked at $3.04M in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on WealthShield Partners's 13F filing for Q4 2024, filed 4 Feb 2025.